# Phase 1 Calculator Validation Report
**Critical Cardiology Calculators Assessment**

## Overview
This report documents the validation findings for the 4 most critical cardiovascular risk calculators as defined in Task 32 Phase 1. Each calculator has been examined for algorithmic accuracy against official medical guidelines and validated using authoritative sources.

---

## üö® CRITICAL ISSUES FOUND

### 1. ASCVD Risk Calculator - **CRITICAL CALIBRATION FAILURE** ‚ùå

**Status**: üö® **ALGORITHM FAILED VALIDATION**  
**Severity**: CRITICAL - All test cases failed systematic validation  
**File**: `src/components/Calculators/ASCVDCalculator.tsx`

#### ‚ùå VALIDATION TEST RESULTS:
**ALL 6 TEST CASES FAILED** - Algorithm requires immediate recalibration

| Test Case | Expected Risk | Calculated Risk | Deviation | Status |
|-----------|---------------|-----------------|-----------|---------|
| White Male (55y) | 7.5% | 10.0% | +2.5% | FAIL ‚ùå |
| AA Female (60y) | 22.3% | 39.9% | +17.6% | FAIL ‚ùå |
| White Female (45y) | 2.1% | 0.4% | -1.7% | FAIL ‚ùå |
| AA Male (65y) | 35.8% | 56.2% | +20.4% | FAIL ‚ùå |
| White Male (50y) | 6.2% | 5.3% | -0.9% | FAIL ‚ùå |
| White Female (62y) | 8.9% | 6.4% | -2.5% | FAIL ‚ùå |

#### üîç Critical Issues Identified:
1. **Systematic Risk Overestimation**: African American patients show +17-20% deviations
2. **Risk Underestimation**: White female patients consistently underestimated  
3. **Coefficient Verification Needed**: Current coefficients don't match expected outputs
4. **Baseline Survival Values**: S‚ÇÄ‚ÇÅ‚ÇÄ probabilities may be incorrect
5. **Mean Centering Issues**: Mean coefficient sums need validation

#### üìä Implementation Status:
- **‚úÖ Algorithm Structure**: Official 2013 ACC/AHA equations implemented
- **‚úÖ Mathematical Model**: Cox proportional hazards formula correct
- **‚ùå Coefficient Accuracy**: Values produce systematic deviations
- **‚ùå Clinical Validation**: Failed all test cases
- **‚ùå Production Ready**: Not safe for clinical use

#### üö® Patient Safety Risk:
- **Risk overestimation** could lead to unnecessary aggressive treatment
- **Risk underestimation** could delay needed cardiovascular therapy
- **Clinical decisions** based on current algorithm could be harmful

#### Required Action: **üö® IMMEDIATE COEFFICIENT CORRECTION REQUIRED**

---

### 2. GRACE Risk Calculator - **MODERATE ALGORITHMIC DEVIATION**

**Status**: ‚ö†Ô∏è **NEEDS IMPROVEMENT**  
**Severity**: MODERATE - Clinical accuracy concern  
**File**: `src/components/Calculators/GRACERiskCalculator.tsx`

#### Issues Identified:
1. **Simplified Scoring**: Using basic point system instead of GRACE 2.0 non-linear equations
2. **Missing Non-Linear Functions**: Official uses restricted cubic splines for continuous variables
3. **No Direct Risk Percentages**: Should provide absolute mortality risk percentages
4. **Missing GRACE 2.0 Features**: No 1-year/3-year mortality calculations

#### Official Requirements (GRACE 2.0):
- **Non-Linear Splines**: For age, SBP, pulse, creatinine (validated in 32,037 patients)
- **Direct Risk Calculation**: Percentage mortality risk (C-statistics >0.82)
- **Baseline Survival Functions**: For 1-year and 3-year mortality
- **Cox Proportional Hazards**: With polynomial curve functions

#### Required Action: **UPGRADE TO GRACE 2.0 SPECIFICATIONS**

---

### 3. CHA‚ÇÇDS‚ÇÇ-VASc Calculator - **PASSES VALIDATION** ‚úÖ

**Status**: ‚úÖ **VALIDATED**  
**Severity**: NONE  
**File**: `src/components/Calculators/AtrialFibrillationCalculators.tsx`

#### Validation Results:
- ‚úÖ **Correct Scoring**: Age 65-74 (1pt), ‚â•75 (2pts), Female (1pt), etc.
- ‚úÖ **Accurate Algorithm**: Matches ESC guidelines exactly
- ‚úÖ **Proper Risk Interpretation**: Correct stroke risk percentages
- ‚úÖ **Clinical Thresholds**: Anticoagulation recommendations accurate

#### Required Action: **NONE - MAINTAIN CURRENT IMPLEMENTATION**

---

### 4. TIMI Risk Score - **PASSES VALIDATION** ‚úÖ

**Status**: ‚úÖ **VALIDATED**  
**Severity**: NONE  
**File**: `src/components/Calculators/TIMIRiskCalculator.tsx`

#### Validation Results:
- ‚úÖ **Correct 7-Point Scale**: All criteria match TIMI study specifications
- ‚úÖ **Accurate Risk Stratification**: Low (0-2), Medium (3-4), High (5-7) categories
- ‚úÖ **Clinical Interpretation**: Correct mortality/ischemia risk percentages
- ‚úÖ **NSTEMI/UA Application**: Appropriate for non-ST elevation ACS

#### Required Action: **NONE - MAINTAIN CURRENT IMPLEMENTATION**

---

## üìä VALIDATION SUMMARY

| Calculator | Status | Severity | Primary Issue | Action Required |
|------------|--------|----------|---------------|-----------------|
| ASCVD | ‚ùå CRITICAL FAILURE | HIGH | Failed all validation tests | Immediate coefficient correction |
| GRACE | ‚ö†Ô∏è NEEDS WORK | MODERATE | Simplified version | Upgrade to 2.0 |
| CHA‚ÇÇDS‚ÇÇ-VASc | ‚úÖ PASS | NONE | None | Maintain |
| TIMI | ‚úÖ PASS | NONE | None | Maintain |

---

## üéØ IMMEDIATE ACTIONS REQUIRED

### Phase 1 Critical Issues (Patient Safety):
1. üö® **CRITICAL: Recalibrate ASCVD algorithm** - All test cases failed validation
2. üîç **Research official coefficient sources** from ACC/AHA and medical literature
3. ‚ö†Ô∏è **Upgrade GRACE to 2.0 specifications** with non-linear functions
4. ‚úÖ **Maintain CHA‚ÇÇDS‚ÇÇ-VASc and TIMI** - both validated successfully

### Implementation Priority:
1. **ASCVD (CRITICAL)**: Algorithm failed validation - immediate coefficient correction needed
2. **Coefficient Research**: Cross-validate against official ACC/AHA Risk Estimator Plus
3. **GRACE (Important)**: Clinical accuracy improvement - upgrade to 2.0
4. **Re-testing**: Complete validation suite after corrections

---

## üîç VALIDATION METHODOLOGY

### Test Execution Results:
- **ASCVD**: 6 comprehensive test cases executed, 0 passed (0% success rate)
- **Systematic deviations**: African American overestimation, White female underestimation
- **Tolerance criteria**: <¬±0.5% deviation required, largest deviation +20.4%
- **Clinical accuracy**: Current algorithm not safe for patient care

### Sources Used:
- **Official ACC/AHA Risk Estimator Plus** (tools.acc.org)
- **GRACE 2.0 Specifications** (gracescore.org)
- **Medical Literature**: Goff et al. Circulation 2014, Fox et al. BMJ Open 2014
- **Clinical Guidelines**: ESC, ACC/AHA, TIMI Study Group

### Standards Applied:
- **< ¬±0.5%** deviation for risk calculations
- **Zero deviation** for clinical decision thresholds
- **Published medical literature** for reference values
- **Official calculator cross-validation**

### Next Steps:
1. **üö® URGENT: Fix ASCVD coefficient implementation** - Patient safety priority
2. **Research official coefficient sources** from peer-reviewed literature
3. **Re-run validation tests** after corrections
4. **Clinical accuracy review** by cardiology experts

---

## üìö REFERENCE SPECIFICATIONS

### Official Algorithm Sources:
- **ASCVD**: 2013 ACC/AHA Pooled Cohort Equations (Goff et al.) - NEEDS COEFFICIENT VERIFICATION
- **GRACE**: GRACE 2.0 Risk Calculator specifications (Fox et al.)
- **CHA‚ÇÇDS‚ÇÇ-VASc**: ESC Atrial Fibrillation Guidelines
- **TIMI**: TIMI Risk Score for UA/NSTEMI (Antman et al.)

### Critical Research Needed:
- **ASCVD coefficient verification** against official sources
- **Baseline survival probability** validation (S‚ÇÄ‚ÇÅ‚ÇÄ values)
- **Mean coefficient values** for proper risk factor centering
- **Cross-validation** with official online calculators

**This validation confirms CRITICAL patient safety issues requiring immediate correction before clinical use.** üö® 